Cargando…

An evaluation index system for regional mobile SARS-CoV-2 virus nucleic acid testing capacity in China: a modified Delphi consensus study

BACKGROUND: Large-scale detection has great potential to bring benefits for containing the COVID-19 epidemic and supporting the government in reopening economic activities. Evaluating the true regional mobile severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus nucleic acid testing cap...

Descripción completa

Detalles Bibliográficos
Autores principales: Di, Dong-sheng, Zhang, Jian-li, Wei, Mu-hong, Zhou, Hao-long, Cui, Yuan, Zhang, Ru-yi, Tong, Ye-qing, Liu, Jun-an, Wang, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399982/
https://www.ncbi.nlm.nih.gov/pubmed/36002820
http://dx.doi.org/10.1186/s12913-022-08446-9
_version_ 1784772649500540928
author Di, Dong-sheng
Zhang, Jian-li
Wei, Mu-hong
Zhou, Hao-long
Cui, Yuan
Zhang, Ru-yi
Tong, Ye-qing
Liu, Jun-an
Wang, Qi
author_facet Di, Dong-sheng
Zhang, Jian-li
Wei, Mu-hong
Zhou, Hao-long
Cui, Yuan
Zhang, Ru-yi
Tong, Ye-qing
Liu, Jun-an
Wang, Qi
author_sort Di, Dong-sheng
collection PubMed
description BACKGROUND: Large-scale detection has great potential to bring benefits for containing the COVID-19 epidemic and supporting the government in reopening economic activities. Evaluating the true regional mobile severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus nucleic acid testing capacity is essential to improve the overall fighting performance against this epidemic and maintain economic development. However, such a tool is not available in this issue. We aimed to establish an evaluation index system for assessing the regional mobile SARS-CoV-2 virus nucleic acid testing capacity and provide suggestions for improving the capacity level. METHODS: The initial version of the evaluation index system was identified based on massive literature and expert interviews. The Delphi method questionnaire was designed and 30 experts were consulted in two rounds of questionnaire to select and revise indexes at all three levels. The Analytic Hierarchy Process method was used to calculate the weight of indexes at all three levels. RESULTS: The evaluation index system for assessing the regional mobile SARS-CoV-2 virus nucleic acid testing capacity, including 5 first-level indexes, 17 second-level indexes, and 90 third-level indexes. The response rates of questionnaires delivered in the two rounds of consultation were 100 and 96.7%. Furthermore, the authority coefficient of 30 experts was 0.71. Kendall’s coordination coefficient differences were statistically significant (P < 0.001). The weighted values of capacity indexes were established at all levels according to the consistency test, demonstrating that ‘Personnel team construction’ (0.2046) came first amongst the five first-level indexes, followed by ‘Laboratory performance building and maintenance’ (0.2023), ‘Emergency response guarantee’ (0.1989), ‘Information management system for nucleic acid testing resources’ (0.1982) and ‘Regional mobile nucleic acid testing emergency response system construction’ (0.1959). CONCLUSION: The evaluation system for assessing the regional mobile SARS-CoV-2 virus nucleic acid testing capacity puts forward a specific, objective, and quantifiable evaluation criterion. The evaluation system can act as a tool for diversified subjects to find the weak links and loopholes. It also provides a measurable basis for authorities to improve nucleic acid testing capabilities.
format Online
Article
Text
id pubmed-9399982
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93999822022-08-24 An evaluation index system for regional mobile SARS-CoV-2 virus nucleic acid testing capacity in China: a modified Delphi consensus study Di, Dong-sheng Zhang, Jian-li Wei, Mu-hong Zhou, Hao-long Cui, Yuan Zhang, Ru-yi Tong, Ye-qing Liu, Jun-an Wang, Qi BMC Health Serv Res Research BACKGROUND: Large-scale detection has great potential to bring benefits for containing the COVID-19 epidemic and supporting the government in reopening economic activities. Evaluating the true regional mobile severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus nucleic acid testing capacity is essential to improve the overall fighting performance against this epidemic and maintain economic development. However, such a tool is not available in this issue. We aimed to establish an evaluation index system for assessing the regional mobile SARS-CoV-2 virus nucleic acid testing capacity and provide suggestions for improving the capacity level. METHODS: The initial version of the evaluation index system was identified based on massive literature and expert interviews. The Delphi method questionnaire was designed and 30 experts were consulted in two rounds of questionnaire to select and revise indexes at all three levels. The Analytic Hierarchy Process method was used to calculate the weight of indexes at all three levels. RESULTS: The evaluation index system for assessing the regional mobile SARS-CoV-2 virus nucleic acid testing capacity, including 5 first-level indexes, 17 second-level indexes, and 90 third-level indexes. The response rates of questionnaires delivered in the two rounds of consultation were 100 and 96.7%. Furthermore, the authority coefficient of 30 experts was 0.71. Kendall’s coordination coefficient differences were statistically significant (P < 0.001). The weighted values of capacity indexes were established at all levels according to the consistency test, demonstrating that ‘Personnel team construction’ (0.2046) came first amongst the five first-level indexes, followed by ‘Laboratory performance building and maintenance’ (0.2023), ‘Emergency response guarantee’ (0.1989), ‘Information management system for nucleic acid testing resources’ (0.1982) and ‘Regional mobile nucleic acid testing emergency response system construction’ (0.1959). CONCLUSION: The evaluation system for assessing the regional mobile SARS-CoV-2 virus nucleic acid testing capacity puts forward a specific, objective, and quantifiable evaluation criterion. The evaluation system can act as a tool for diversified subjects to find the weak links and loopholes. It also provides a measurable basis for authorities to improve nucleic acid testing capabilities. BioMed Central 2022-08-24 /pmc/articles/PMC9399982/ /pubmed/36002820 http://dx.doi.org/10.1186/s12913-022-08446-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Di, Dong-sheng
Zhang, Jian-li
Wei, Mu-hong
Zhou, Hao-long
Cui, Yuan
Zhang, Ru-yi
Tong, Ye-qing
Liu, Jun-an
Wang, Qi
An evaluation index system for regional mobile SARS-CoV-2 virus nucleic acid testing capacity in China: a modified Delphi consensus study
title An evaluation index system for regional mobile SARS-CoV-2 virus nucleic acid testing capacity in China: a modified Delphi consensus study
title_full An evaluation index system for regional mobile SARS-CoV-2 virus nucleic acid testing capacity in China: a modified Delphi consensus study
title_fullStr An evaluation index system for regional mobile SARS-CoV-2 virus nucleic acid testing capacity in China: a modified Delphi consensus study
title_full_unstemmed An evaluation index system for regional mobile SARS-CoV-2 virus nucleic acid testing capacity in China: a modified Delphi consensus study
title_short An evaluation index system for regional mobile SARS-CoV-2 virus nucleic acid testing capacity in China: a modified Delphi consensus study
title_sort evaluation index system for regional mobile sars-cov-2 virus nucleic acid testing capacity in china: a modified delphi consensus study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399982/
https://www.ncbi.nlm.nih.gov/pubmed/36002820
http://dx.doi.org/10.1186/s12913-022-08446-9
work_keys_str_mv AT didongsheng anevaluationindexsystemforregionalmobilesarscov2virusnucleicacidtestingcapacityinchinaamodifieddelphiconsensusstudy
AT zhangjianli anevaluationindexsystemforregionalmobilesarscov2virusnucleicacidtestingcapacityinchinaamodifieddelphiconsensusstudy
AT weimuhong anevaluationindexsystemforregionalmobilesarscov2virusnucleicacidtestingcapacityinchinaamodifieddelphiconsensusstudy
AT zhouhaolong anevaluationindexsystemforregionalmobilesarscov2virusnucleicacidtestingcapacityinchinaamodifieddelphiconsensusstudy
AT cuiyuan anevaluationindexsystemforregionalmobilesarscov2virusnucleicacidtestingcapacityinchinaamodifieddelphiconsensusstudy
AT zhangruyi anevaluationindexsystemforregionalmobilesarscov2virusnucleicacidtestingcapacityinchinaamodifieddelphiconsensusstudy
AT tongyeqing anevaluationindexsystemforregionalmobilesarscov2virusnucleicacidtestingcapacityinchinaamodifieddelphiconsensusstudy
AT liujunan anevaluationindexsystemforregionalmobilesarscov2virusnucleicacidtestingcapacityinchinaamodifieddelphiconsensusstudy
AT wangqi anevaluationindexsystemforregionalmobilesarscov2virusnucleicacidtestingcapacityinchinaamodifieddelphiconsensusstudy
AT didongsheng evaluationindexsystemforregionalmobilesarscov2virusnucleicacidtestingcapacityinchinaamodifieddelphiconsensusstudy
AT zhangjianli evaluationindexsystemforregionalmobilesarscov2virusnucleicacidtestingcapacityinchinaamodifieddelphiconsensusstudy
AT weimuhong evaluationindexsystemforregionalmobilesarscov2virusnucleicacidtestingcapacityinchinaamodifieddelphiconsensusstudy
AT zhouhaolong evaluationindexsystemforregionalmobilesarscov2virusnucleicacidtestingcapacityinchinaamodifieddelphiconsensusstudy
AT cuiyuan evaluationindexsystemforregionalmobilesarscov2virusnucleicacidtestingcapacityinchinaamodifieddelphiconsensusstudy
AT zhangruyi evaluationindexsystemforregionalmobilesarscov2virusnucleicacidtestingcapacityinchinaamodifieddelphiconsensusstudy
AT tongyeqing evaluationindexsystemforregionalmobilesarscov2virusnucleicacidtestingcapacityinchinaamodifieddelphiconsensusstudy
AT liujunan evaluationindexsystemforregionalmobilesarscov2virusnucleicacidtestingcapacityinchinaamodifieddelphiconsensusstudy
AT wangqi evaluationindexsystemforregionalmobilesarscov2virusnucleicacidtestingcapacityinchinaamodifieddelphiconsensusstudy